Upgrade to SI Premium - Free Trial

Sage Therapeutics (SAGE) PT Raised to $95 at Needham & Company

August 4, 2017 7:27 AM
Needham & Company raised its price target on Sage Therapeutics (NASDAQ: SAGE) to $95.00 (from $82.00) while maintaining a Buy ...

(Premium-only article. Please sign in or upgrade to SI Premium to view.)

Categories

Analyst Comments Analyst PT Change

Next Articles